Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Linde
LIN
|
$588M |
| 2 |
Apple
AAPL
|
$574M |
| 3 |
Illumina
ILMN
|
$398M |
| 4 |
argenx
ARGX
|
$306M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
$250M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$600M |
| 2 |
AbbVie
ABBV
|
$323M |
| 3 |
Sherwin-Williams
SHW
|
$309M |
| 4 |
Atlassian
TEAM
|
$250M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$241M |
Sector Composition
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.43% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2451
American Well
AMWL
$113M
| $215K | ﹤0.01% |
4,590
+2,471
| +117% | +$116K |
|
|
INBX
2452
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $215K | ﹤0.01% |
+11,391
| New | +$215K |
|
|
SAVE
2453
DELISTED
Spirit Airlines, Inc.
SAVE
| $215K | ﹤0.01% |
+12,531
| New | +$215K |
|
|
PNT
2454
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $215K | ﹤0.01% |
29,554
+15,616
| +112% | +$113K |
|
2455
Thryv Holdings
THRY
$549M
| $214K | ﹤0.01% |
+9,295
| New | +$214K |
|
2456
Treace Medical Concepts
TMCI
$453M
| $214K | ﹤0.01% |
8,489
-534,791
| -98% | -$13.5M |
|
2457
Haverty Furniture Companies
HVT
$390M
| $214K | ﹤0.01% |
+6,707
| New | +$214K |
|
2458
V2X
VVX
$1.79B
| $214K | ﹤0.01% |
+5,382
| New | +$214K |
|
2459
AMC Networks
AMCX
$328M
| $214K | ﹤0.01% |
+12,150
| New | +$214K |
|
2460
Merus
MRUS
$5.1B
| $213K | ﹤0.01% |
+11,614
| New | +$213K |
|
2461
Independent Bank Corp
IBCP
$680M
| $213K | ﹤0.01% |
+11,989
| New | +$213K |
|
2462
British American Tobacco
BTI
$122B
| $213K | ﹤0.01% |
6,055
-1,453
| -19% | -$51K |
|
|
TPIC
2463
DELISTED
TPI Composites
TPIC
| $212K | ﹤0.01% |
+16,253
| New | +$212K |
|
|
GOOD
2464
Gladstone Commercial Corp
GOOD
$616M
| $212K | ﹤0.01% |
+16,790
| New | +$212K |
|
2465
Castle Biosciences
CSTL
$683M
| $211K | ﹤0.01% |
+9,296
| New | +$211K |
|
2466
Emergent Biosolutions
EBS
$404M
| $211K | ﹤0.01% |
20,348
-47,024
| -70% | -$487K |
|
2467
Hackett Group
HCKT
$576M
| $210K | ﹤0.01% |
+11,341
| New | +$210K |
|
2468
Interface
TILE
$1.64B
| $209K | ﹤0.01% |
25,798
+13,881
| +116% | +$113K |
|
2469
Xperi
XPER
$284M
| $209K | ﹤0.01% |
+19,154
| New | +$209K |
|
2470
ANI Pharmaceuticals
ANIP
$2.07B
| $209K | ﹤0.01% |
+5,262
| New | +$209K |
|
2471
Mercantile Bank Corp
MBWM
$791M
| $209K | ﹤0.01% |
+6,834
| New | +$209K |
|
2472
Perella Weinberg Partners
PWP
$1.39B
| $207K | ﹤0.01% |
22,848
+10,494
| +85% | +$95.3K |
|
2473
UiPath
PATH
$6.15B
| $207K | ﹤0.01% |
11,810
+65
| +0.6% | +$1.14K |
|
2474
Carriage Services
CSV
$671M
| $207K | ﹤0.01% |
+6,793
| New | +$207K |
|
|
SCPL
2475
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $206K | ﹤0.01% |
+12,129
| New | +$206K |
|